Filing Flows › Vycor Medical (VYCO) › Q2 2026
Vycor Medical (VYCO) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 14, 2026
Vycor Medical (VYCO) reported revenue of $418K for the second quarter 2026 (Q2 2026), -16% from a year earlier and -9% from the quarter before. Operating margin was 1.6%, net loss $22K (5.3% of revenue).
Vycor Medical, Q2 2026: revenue $418K (-16% year over year), operating margin 1.6%, net loss $22K, operating cash flow −$5K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $418K | -9% | -16% |
| Operating profit | $7K | -85% | -87% |
| Net earnings | −$22K | -211% | -193% |
| Operating cash flow | −$5K | -105% | -110% |
What changed
Revenue was $418K in Q2 2026, down 16% year over year and down 9% from the previous quarter. Vycor Medical Inc was the largest line at 96% of revenue. Vycor Medical Inc lost $81K year over year (down 17%), 103% of the total change.
Gross margin was 82.4%, down 1.3 points from Q2 2025. Operating profit was $7K, a 1.6% margin (down 8.7 points year over year). Operating expenses fell 7% while revenue fell 16%. The quarter ended with a net loss of $22K, after a profit of $20K the previous quarter. Net interest and other expense of $26K was the main reason.
Operating cash flow was −$5K. Non-cash charges added back $15K of depreciation and amortization. Working capital and other items added $3K.
Questions
What was Vycor Medical's revenue in the second quarter 2026?
Vycor Medical (VYCO) reported revenue of $418K for the second quarter 2026 (Q2 2026), -16% from a year earlier and -9% from the quarter before.
Was Vycor Medical profitable in the second quarter 2026?
Operating profit was $7K (1.6% of revenue) and net loss $22K.
Source: Vycor Medical 10-Q on SEC EDGAR.